Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Cellular Signalling
|
February 18, 2024
Deciphering disulfidptosis: Uncovering a lncRNA-based signature for prognostic assessment, personalized immunotherapy, and therapeutic agent selection in lung adenocarcinoma patients
Chao Ma, Huan Zhao, Yang Sun, et al.
Biomarker Research
|
January 16, 2024
Targeting TIGIT for cancer immunotherapy: recent advances and future directions
Peng Zhang, Xinyuan Liu, Zhuoyu Gu, et al.
Frontiers in Genetics
|
February 28, 2022
High Expression of PLAGL2 is Associated With Poor Prognosis in High-Grade Glioma
Gang Wang, Wei Du, Lingyi Che, et al.
Journal of Hematology & Oncology
|
September 16, 2018
Overexpression of CLC-3 is regulated by XRCC5 and is a poor prognostic biomarker for gastric cancer
Zhuoyu Gu, Yixin Li, Xiaoya Yang, et al.
International Journal of Biological Sciences
|
November 28, 2022
Stearoyl-CoA Desaturase-1 dependent lipid droplets accumulation in cancer-associated fibroblasts facilitates the progression of lung cancer
Yana Zhang, Zhuoyu Gu, Jiajia Wan, et al.
Journal of Cellular and Molecular Medicine
|
May 4, 2021
HIF-1α is necessary for activation and tumour-promotion effect of cancer-associated fibroblasts in lung cancer
Yana Zhang, Yangyang Bian, Yuan Wang, et al.
Pharmacogenomics and Personalized Medicine
|
June 9, 2023
Leucyl and Cystinyl Aminopeptidase as a Prognostic-Related Biomarker in OV Correlating with Immune Infiltrates
Qian Ma, Lei Chang, Wenwen Wang, et al.
International Journal of Biological Sciences
|
November 28, 2022
HNRNPK/CLCN3 axis facilitates the progression of LUAD through CAF-tumor interaction
Yixin Li, Yang Yang, Qian Ma, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
January 29, 2026
Exploring the mechanism of Cucurbitacin B against myocardial ischemia reperfusion injury based on network pharmacology and experimental validation
Xingdong Cheng, Dengyan Zhu, Haizhou Guo, et al.
Cell Death & Disease
|
October 23, 2020
ClC-3/SGK1 regulatory axis enhances the olaparib-induced antitumor effect in human stomach adenocarcinoma
Zhuoyu Gu, Liping Wang, Xiaohan Yao, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Cellular Signalling
|
February 18, 2024
Deciphering disulfidptosis: Uncovering a lncRNA-based signature for prognostic assessment, personalized immunotherapy, and therapeutic agent selection in lung adenocarcinoma patients
Chao Ma, Huan Zhao, Yang Sun, et al.
Biomarker Research
|
January 16, 2024
Targeting TIGIT for cancer immunotherapy: recent advances and future directions
Peng Zhang, Xinyuan Liu, Zhuoyu Gu, et al.
Frontiers in Genetics
|
February 28, 2022
High Expression of PLAGL2 is Associated With Poor Prognosis in High-Grade Glioma
Gang Wang, Wei Du, Lingyi Che, et al.
Journal of Hematology & Oncology
|
September 16, 2018
Overexpression of CLC-3 is regulated by XRCC5 and is a poor prognostic biomarker for gastric cancer
Zhuoyu Gu, Yixin Li, Xiaoya Yang, et al.
International Journal of Biological Sciences
|
November 28, 2022
Stearoyl-CoA Desaturase-1 dependent lipid droplets accumulation in cancer-associated fibroblasts facilitates the progression of lung cancer
Yana Zhang, Zhuoyu Gu, Jiajia Wan, et al.
Journal of Cellular and Molecular Medicine
|
May 4, 2021
HIF-1α is necessary for activation and tumour-promotion effect of cancer-associated fibroblasts in lung cancer
Yana Zhang, Yangyang Bian, Yuan Wang, et al.
Pharmacogenomics and Personalized Medicine
|
June 9, 2023
Leucyl and Cystinyl Aminopeptidase as a Prognostic-Related Biomarker in OV Correlating with Immune Infiltrates
Qian Ma, Lei Chang, Wenwen Wang, et al.
International Journal of Biological Sciences
|
November 28, 2022
HNRNPK/CLCN3 axis facilitates the progression of LUAD through CAF-tumor interaction
Yixin Li, Yang Yang, Qian Ma, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
January 29, 2026
Exploring the mechanism of Cucurbitacin B against myocardial ischemia reperfusion injury based on network pharmacology and experimental validation
Xingdong Cheng, Dengyan Zhu, Haizhou Guo, et al.
Cell Death & Disease
|
October 23, 2020
ClC-3/SGK1 regulatory axis enhances the olaparib-induced antitumor effect in human stomach adenocarcinoma
Zhuoyu Gu, Liping Wang, Xiaohan Yao, et al.
Page
of 4